847659-90-9

Upstream product

• 847659-89-6 (4S,4'S,5R,5'R)-5'-(tert-butyldiphenylsilyloxy)-2,2'-diphenyl-4,4'-bi(1,3-dioxan)-5-yl methanesulfonate 

Downstream Products

• 1138325-27-5 (R)-2-(benzyloxy)-1-((4S,5S)-5-((R)-2-(benzyloxy)-1-(tert-butyldiphenylsilyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethyl methanesulfonate 
• 1360594-40-6 {(1S,2R)-3-benzyloxy-1-[(2R,3S)-3-(benzyloxymethyl)oxiran-2-yl]-1-methoxypropan-2-yloxy}(tert-butyl)diphenylsilane 
• 1138325-28-6 (R)-1-((4S,5S)-5-((R)-1-(tert-butyldiphenylsilyloxy)-2-hydroxyethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl methanesulfonate 
• 1138325-29-7 (R)-2-(tert-butyldiphenylsilyloxy)-1-((4R,5R)-2,2-dimethyl-5-((S)-oxiran-2-yl)-1,3-dioxolan-4-yl)ethanol 
• 1138325-30-0 C₂₆H₃₃F₃O₇SSi 
• 1138325-31-1 ((S)-2-azido-2-((4R,5S)-2,2-dimethyl-5-((S)-oxiran-2-yl)-1,3-dioxolan-4-yl)ethoxy)(tert-butyl)diphenylsilane 
• 1138325-32-2 (S)-2-(tert-butyldiphenylsilyloxy)-1-((4R,5S)-2,2-dimethyl-5-((S)-oxiran-2-yl)-1,3-dioxolan-4-yl)ethanamine 
• 1360594-42-8 C₃₀H₄₃NO₆Si 
• 1360594-41-7 tert-butyl (S)-1-{(4R,5R)-5-[(S)-2-azido-1-hydroxyethyl]-2,2-dimethyl-1,3-dioxolan-4-yl}-2-(tert-butyldiphenylsilyloxy)ethylcarbamate 
• 1360594-43-9 C₃₅H₅₄N₂O₈Si 
• 1360594-44-0 (S)-2-(tert-butoxycarbonyl)-1-{(4S,5R)-5-[(S)-1-(tert-butoxycarbonyl)-2-(tert-butyldiphenylsilyloxy)ethyl]-2,2-dimethyl-1,3-dioxolan-4-yl}ethyl methanesulfonate 
• 1360594-45-1 tert-butyl (2R)-2-{(4R,5R)-5-[(S)-1-(tert-butoxycarbonyl)-2-(tertbutyldiphenylsilyloxy)ethyl]-2,2-dimethyl-1,3-dioxolan-4-yl}aziridine-1-carboxylate 
• 1360594-46-2 (3aR,4S,8S,8aR)-4-(azidomethyl)-8-[(tert-butyldiphenylsilyloxy)methyl]-2,2-dimethyltetrahydro-[1,3]dioxolo[4,5-e][1,3]-oxazepin-6(7H)-one 
• 1360594-47-3 (S)-1-{(4R,5R)-5-[(S)-1-amino-2-(tert-butyldiphenylsilyloxy)ethyl]-2,2-dimethyl-1,3-dioxolan-4-yl}ethanol 

Relevant academic research and scientific papers

Diversity-oriented synthesis of useful chiral building blocks from D-mannitol

A diversity-oriented synthesis is described for functionalized chiral building blocks (i.e., 7, 9, 10, 16, and 17) and the biologically active iminosugar, fucosidase inhibitor (2S,3R,4R,5R)-2-(hydroxymethyl)-5- methylpyrrolidine-3,4-diol (22), starting fr

1,3:4,6-Di-O-benzylidene-D-mannitol as a source for novel chiral intermediates through regioselective reductive cleavage

Synthetically useful chiral intermediates have been synthesized starting from 1,3:4,6-di-O-benzylidene-D-mannitol by regioselective reductive cleavage using BF3?Et2O and Et3SiH in high yields.